12 results
Antiplatelet Conversion - Switching Between P2Y12 Inhibitors
Oral P2Y12 inhibitors vary in potency and pharmacokinetic and dynamic
Antiplatelet Conversion ... Oral P2Y12 inhibitors ... Cangrelor) and Oral ... Switching Among Oral ... ticagrelor #prasugrel #pharmacology
Transdermal Fentanyl require unique dosing conversions. For Adult and pediatric patients taking opiouds or doses not
require unique dosing ... conversions. ... the equinalgesic oral ... #Pharmacology #Pain ... Opiate #Opioid #Conversion
Comparison of oral anticoagulant agents (DOACS + Warfarin)

Reference: ENLS 2017 Pharmacotherapy. Neurocritical Care Journal.

#DOAC #Dosing #Oral
Comparison of oral ... #DOAC #Dosing #Oral ... Anticoagulation #Comparison ... #Table #Pharmacology
Xa Inhibitors - Apixaban and Rivaroxaban 
Oral Xa inhibitors are recommended by CHEST as first-line for
Xa Inhibitors - ... Rivaroxaban Oral ... Xa inhibitors are ... patients with normal ... #Pharmacology
Oral P2Y12 Inhibitor Pharmacology

 • Clopidogrel
 • Prasugrel
 • Ticagrelor

By Kyle Fischer, PharmD @Kfischer_10

#P2Y12 #Inhibitor #Pharmacology
Oral P2Y12 Inhibitor ... Pharmacology ... _10 #P2Y12 #Inhibitor ... #Pharmacology # ... comparison #table
Intern Pocket Cards - Pharmacologic Pain Management Options
Anti-inflammatory:
 • Acetaminophen (24 hours: < 3-4g in healthy
Pocket Cards - Pharmacologic ... cirrhosis) • Oral ... Equianalgesia Conversion ... #Pain #Opioid #Conversion ... internship #guide #comparison
Antiplatelet Conversion - Switching Between Oral P2Y12 Inhibitors
A, Switching between oral agents in the acute/early phase.
Switching Between Oral ... Switching between oral ... the timing and dosing ... Switching between oral ... ticagrelor #prasugrel #pharmacology
Bisphosphonates for Osteoporosis Treatment or Prevention 

Bisphosphonates are common medications used in the treatment and prevention
are a variety of dosing ... Bisphosophonates inhibit ... is to take the oral ... Bisphosphonates #Dosing ... Schedule #Frequency #Pharmacology
Veltassa (Patiromer) 
MECHANISM: Potassium Binder 
INDICATION: Treatment of Hyperkalemia 
FORMULATION: Powder for oral suspension 
DOSING: 8.4
FORMULATION: Powder for oral ... suspension DOSING ... separate from other oral ... ACE inhibitors, ... is taken as an oral
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB)
 •
IDSA - Clinical ... five effective oral ... If needed or if oral ... antimicrobials #regimens #pharmacology ... #dosing #idsa #